WAVE LIFE SCIENCES ($WVE) is expected to release its quarterly earnings data on Tuesday, March 4th before market open, per Finnhub. Analysts are expecting revenue of $28,315,653 and earnings of -$0.18 per share.
You can see Quiver Quantitative's $WVE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WAVE LIFE SCIENCES Insider Trading Activity
WAVE LIFE SCIENCES insiders have traded $WVE stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $WVE stock by insiders over the last 6 months:
- PLC GSK purchased 2,791,930 shares for an estimated $22,335,440
- CHRIS FRANCIS (See Remarks) has made 0 purchases and 5 sales selling 244,836 shares for an estimated $3,431,050.
- PAUL BOLNO (President and CEO) has made 0 purchases and 3 sales selling 191,708 shares for an estimated $2,840,780.
- KYLE MORAN (Chief Financial Officer) sold 17,146 shares for an estimated $154,314
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
WAVE LIFE SCIENCES Hedge Fund Activity
We have seen 115 institutional investors add shares of WAVE LIFE SCIENCES stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARTAL GROUP S.A. removed 4,566,251 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $37,443,258
- BLACKROCK, INC. added 2,061,740 shares (+28.2%) to their portfolio in Q4 2024, for an estimated $25,503,723
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,972,262 shares (+63.1%) to their portfolio in Q4 2024, for an estimated $24,396,880
- SIREN, L.L.C. removed 1,970,681 shares (-34.4%) from their portfolio in Q4 2024, for an estimated $24,377,323
- MAVERICK CAPITAL LTD removed 1,786,278 shares (-17.8%) from their portfolio in Q4 2024, for an estimated $22,096,258
- LOOMIS SAYLES & CO L P added 1,660,866 shares (+inf%) to their portfolio in Q4 2024, for an estimated $20,544,912
- TAKEDA PHARMACEUTICAL CO LTD removed 1,346,892 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $16,661,054
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
